Impairment of peripheral nervous system in patients with non-Hodgkin's lymphomas treated with CBVPM/AVBP and CHOP schedules

Acta Haematol Pol. 1992;23(2):111-6.

Abstract

Clinical examination and conduction velocity measurements in peripheral nerves have been done on 56 patients with non-Hodgkin's lymphomas of high malignancy (NHL). It is suggested that: the evaluation of the influence of chemotherapy on peripheral nervous system (PNS) is possible by means of systematic neurological and electroneurographic studies; electroneurographic assessment is most important in the diagnosis of early subclinical stages of peripheral neuropathy; toxic influence of CBVPM/AVBP protocol on PNS is greater than CHOP schedule; impairment of PNS due to chemotherapy is reversible in patients during complete remission (CR).

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Female
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / physiopathology
  • Male
  • Median Nerve / drug effects*
  • Median Nerve / physiopathology
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Middle Aged
  • Neural Conduction / drug effects
  • Neural Conduction / physiology
  • Peroneal Nerve / drug effects*
  • Peroneal Nerve / physiopathology
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Reflex, Abnormal / drug effects*
  • Reflex, Abnormal / physiology
  • Reflex, Stretch / drug effects*
  • Reflex, Stretch / physiology
  • Ulnar Nerve / drug effects*
  • Ulnar Nerve / physiopathology
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Bleomycin
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
  • Methotrexate

Supplementary concepts

  • AVBP protocol
  • CBVPM protocol
  • CHOP protocol